The patents cover sales of Biogen products for MS that are covered by a Forward Pharma patent and have dimethyl fumarate as an active pharmaceutical ingredient. The two companies say they intend ...

We recently compiled a list of ... 13.60 Biogen Inc. (NASDAQ:BIIB) is a biopharmaceutical company focused on neurological and neurodegenerative diseases. Its key products include Avonex, Plegridy ...

Since its approval in 2023, the Alzheimer's disease drug made by Biogen Inc. and Eisai Inc ... slower launch than what we might see for other products,” he said. “That’s simply because ...

Jan 10 (Reuters) - Drugmaker Biogen (BIIB.O), opens new tab will buy all outstanding shares of Sage Therapeutics (SAGE.O), opens new tab that it does not already own for $7.22 apiece, a filing ...